Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes

European Archives of Psychiatry and Clinical Neuroscience

Volumn 261, Issue 7, 2011, Pages 477-482

  Steiner, Johann ^a,b   Sarnyai, Zoltán ^b   Westphal, Sabine ^a   Gos, Tomasz ^a,c   Bernstein, Hans Gert ^a   Bogerts, Bernhard ^a   Keilhoff, Gerburg ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Clozapine; Haloperidol; Oligodendrocytes; OLN 93 cells; Schizophrenia

Indexed keywords

CASPASE 3; CLOZAPINE; GLUCOSE; HALOPERIDOL; PROPIDIUM IODIDE; ANTIGEN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CHONDROITIN SULFATE PROTEOGLYCAN 4; NERVE PROTEIN; NEUROLEPTIC AGENT; OLIG1 PROTEIN, RAT; OLIG2 PROTEIN, RAT; PROTEOGLYCAN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL DEATH; CELL MATURATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; IMMUNOCYTOCHEMISTRY; OLIGODENDROGLIA; PRIORITY JOURNAL; SCHIZOPHRENIA; ANIMAL; CELL LINE; CULTURE MEDIUM; DOSE RESPONSE; METABOLISM; RAT;

ANIMALS; ANTIGENS; ANTIPSYCHOTIC AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASPASE 3; CELL LINE, TRANSFORMED; CLOZAPINE; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; HALOPERIDOL; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PROTEOGLYCANS; RATS;

EID: 84856262695     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-011-0197-3     Document Type: Article

References (40)

1. Begre S, Koenig T (2008) Cerebral disconnectivity: an early event in schizophrenia. Neuroscientist 14:19-45
2. Bernstein HG, Steiner J, Bogerts B (2009) Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Rev Neurother 9:1059-1071
3. Buckinx R, Smolders I, Sahebali S, Janssen D, Smets I, Ameloot M, Rigo JM (2009) Morphological changes do not reflect biochemical and functional differentiation in OLN-93 oligodendroglial cells. J Neurosci Methods 184:1-9
4. Chesik D, De Keyser J, Wilczak N (2008) Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS. J Mol Neurosci 35:81-90
5. Ellison-Wright I, Bullmore E (2009) Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res 108:3-10
6. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA (2004) Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36:131-137 (Pubitemid 38174370)
7. Fernandez-Egea E, Bernardo M, Parellada E, Justicia A, Garcia-Rizo C, Esmatjes E, Conget I, Kirkpatrick B (2008) Glucose abnormalities in the siblings of people with schizophrenia. Schizophr Res 103:110-113
8. Freyberg Z, Ferrando SJ, Javitch JA (2010) Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am J Psychiatry 167:388-396
9. Garver DL, Holcomb JA, Christensen JD (2008) Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. Int J Neuropsychopharmacol 11:49-61
10. Hazlett EA, Buchsbaum MS, Jeu LA, Nenadic I, Fleischman MB, Shihabuddin L, Haznedar MM, Harvey PD (2000) Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task. Schizophr Res 43:33-46 (Pubitemid 30316315)
11. Hof PR, Haroutunian V, Friedrich VL Jr, Byne W, Buitron C, Perl DP, Davis KL (2003) Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53:1075-1085 (Pubitemid 36695083)
12. Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Nicholson JK, Bahn S (2006) Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 3:e327
13. Huang JT, Leweke FM, Tsang TM, Koethe D, Kranaster L, Gerth CW, Gross S, Schreiber D, Ruhrmann S, Schultze-Lutter F, Klosterkotter J, Holmes E, Bahn S (2007) CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS ONE 2:e756
14. Katsel P, Davis KL, Li C, Tan W, Greenstein E, Kleiner Hoffman LB, Haroutunian V (2008) Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacol 33:2993-3009
15. Koch K, Wagner G, Dahnke R, Schachtzabel C, Schultz C, Roebel M, Gullmar D, Reichenbach JR, Sauer H, Schlosser RG (2010) Disrupted white matter integrity of corticopontinecerebellar circuitry in schizophrenia. Eur Arch Psychiatry Clin Neurosci 260:419-426
16. Konopaske GT, Dorph-Petersen KA, Sweet RA, Pierri JN, Zhang W, Sampson AR, Lewis DA (2008) Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry 63:759-765 (Pubitemid 351400762)
17. Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA (2003) Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Am J Psychiatry 160:290-296 (Pubitemid 41110454)
18. Martins-de-Souza D (2010) Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. J Psychiatr Res 44:149-156
19. Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Turck CW, Dias-Neto E (2009) Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 9:17
20. Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Maccarrone G, Dias-Neto E, Turck CW (2009) Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur Arch Psychiatry Clin Neurosci 259:151-163
21. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P (2002) Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22:2718-2729 (Pubitemid 37465821)
22. Mitelman SA, Byne W, Kemether EM, Hazlett EA, Buchsbaum MS (2005) Metabolic disconnection between the mediodorsal nucleus of the thalamus and cortical Brodmann's areas of the left hemisphere in schizophrenia. Am J Psychiatry 162:1733-1735 (Pubitemid 41318244)
23. Narayan S, Kass KE, Thomas EA (2007) Chronic haloperidol treatment results in a decrease in the expression of myelin/oligodendrocyterelated genes in the mouse brain. J Neurosci Res 85:757-765 (Pubitemid 46426075)
24. Niu J, Mei F, Li N, Wang H, Li X, Kong J, Xiao L (2010) Haloperidol promotes proliferation but inhibits differentiation in rat oligodendrocyte progenitor cell cultures. Biochem Cell Biol 88:611-620
25. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:684-697 (Pubitemid 38932173)
26. Richter-Landsberg C, Heinrich M (1996) OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J Neurosci Res 45:161-173 (Pubitemid 26257317)
27. Ryan MC, Collins P, Thakore JH (2003) Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 160:284-289 (Pubitemid 41110453)
28. Schmitt A, Steyskal C, Bernstein HG, Schneider-Axmann T, Parlapani E, Schaeffer EL, Gattaz WF, Bogerts B, Schmitz C, Falkai P (2009) Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol 117:395-407
29. Steiner J, Bernstein HG, Bogerts B, Gos T, Richter-Landsberg C, Wunderlich MT, Keilhoff G (2008) S100B is expressed in, and released from, OLN-93 oligodendrocytes: influence of serum and glucose deprivation. Neuroscience 154:496-503
30. Steiner J, Schroeter ML, Schiltz K, Bernstein HG, Muller UJ, Richter-Landsberg C, Muller WE, Walter M, Gos T, Bogerts B, Keilhoff G (2010) Haloperidol and clozapine decrease S100B release from glial cells. Neuroscience 167:1025-1031
31. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S (2003) Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362:798-805 (Pubitemid 37093922)
32. Uranova NA, Orlovskaia DD, Vikhreva OV, Zimina IS, Rakhmanova VI (2001) Morphometric study of ultrastructural changes in oligodendroglial cells in the postmortem brain in endogenous psychoses. Vestn Ross Akad Med Nauk 7:42-48
33. Venkatasubramanian G, Chittiprol S, Neelakantachar N, Naveen MN, Thirthall J, Gangadhar BN, Shetty KT (2007) Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia. Am J Psychiatry 164:1557-1560 (Pubitemid 350069735)
34. Vostrikov VM, Uranova NA, Orlovskaya DD (2007) Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophr Res 94:273-280 (Pubitemid 47031593)
35. Wang H, Xu H, Niu J, Mei F, Li X, Kong J, Cai W, Xiao L (2010) Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain. Schizophr Res 119:164-174
36. Xiao L, Xu H, Zhang Y, Wei Z, He J, Jiang W, Li X, Dyck LE, Devon RM, Deng Y, Li XM (2008) Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol Psychiatry 13:697-708 (Pubitemid 351861531)
37. Yazici MK, Anil Yagcioglu AE, Ertugrul A, Eni N, Karahan S, Karaagaoglu E, Tokgozoglu SL (2011) The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey. Eur Arch Psychiatry Clin Neurosci [in press]
38. Zhang G, Terry AV Jr, Bartlett MG (2007) Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue. J Chromatogr B Analyt Technol Biomed Life Sci 858:276-281 (Pubitemid 47513594)
39. Zhang Y, Xu H, Jiang W, Xiao L, Yan B, He J, Wang Y, Bi X, Li X, Kong J, Li XM (2008) Quetiapine alleviates the cuprizoneinduced white matter pathology in the brain of C57BL/6 mouse. Schizophr Res 106:182-191
40. Zhao Z, Ksiezak-Reding H, Riggio S, Haroutunian V, Pasinetti GM (2006) Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophr Res 84:1-14